Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. is a Private limited company (Ltd.) registered in United States under 7062770, and its current status with Pennsylvania Department of State is active. The company was incorporated on 20 May 2020 and lists its registered address as United States. 4 shareholders are on record for Palvella Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Pennsylvania Department of State and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for Palvella Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 7.4% — the largest recorded stake — followed by Jennison Associates LLC at 5.1%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 7.4% | Pennsylvania Department of State | |
| Jennison Associates LLC | 5.1% | Pennsylvania Department of State | |
| iShares Trust-iShares Russell 2000 ETF | 2.4% | Pennsylvania Department of State | |
| Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund | 2.1% | Pennsylvania Department of State |
Officers
5
The Founder, President, Ceo & Director of Palvella Therapeutics, Inc. currently on record is Wesley H. Kaupinen; five officers are currently on record for Palvella Therapeutics, Inc., filed with Pennsylvania Department of State.
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Palvella Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Palvella Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Palvella Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Palvella Therapeutics, Inc.?
Four shareholders are currently on record for Palvella Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 7.4% — the largest recorded stake — followed by Jennison Associates LLC at 5.1%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Palvella Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Palvella Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Palvella Therapeutics, Inc. have on record?
4 shareholders are shown on record for Palvella Therapeutics, Inc..
What is Palvella Therapeutics, Inc.'s company registration number?
Palvella Therapeutics, Inc.'s registration number is 7062770, filed with Pennsylvania Department of State in United States. Its current status on the register is active.
Is Palvella Therapeutics, Inc. still an active company?
Palvella Therapeutics, Inc.'s status on Pennsylvania Department of State is listed as active.
When was Palvella Therapeutics, Inc. incorporated?
Palvella Therapeutics, Inc. was incorporated on 20 May 2020, according to Pennsylvania Department of State.
What is Palvella Therapeutics, Inc.'s registered address?
The registered address on file for Palvella Therapeutics, Inc. is United States.
What legal structure is Palvella Therapeutics, Inc. registered as?
Palvella Therapeutics, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of Palvella Therapeutics, Inc.?
The Founder, President, Ceo & Director of Palvella Therapeutics, Inc. currently on record is Wesley H. Kaupinen; five officers are currently on record for Palvella Therapeutics, Inc., filed with Pennsylvania Department of State. Management authority at Palvella Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Palvella Therapeutics, Inc. have a parent company or subsidiaries?
Palvella Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Palvella Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Pennsylvania Department of State. Zavia's monitoring API can track changes to Palvella Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Palvella Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Palvella Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Pennsylvania Department of State and was last synced on 5 October 2026.